B-Cell Receptor-Associated Protein 31 (BCAP31) (Middle Region) Peptide
Quick Overview for B-Cell Receptor-Associated Protein 31 (BCAP31) (Middle Region) Peptide (ABIN973765)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-BCAP31 antibody (Catalog #: ARP46645_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- BCAP31 (B-Cell Receptor-Associated Protein 31 (BCAP31))
-
Background
-
BCAP31 is a member of the B-cell receptor associated protein 31 superfamily. It is a multi-pass transmembrane protein of the endoplasmic reticulum that is involved in the anterograde transport of membrane proteins from the endoplasmic reticulum to the Golgi and in the caspase 8-mediated apoptosis. Microdeletions in this gene are associated with the contiguous ABCD1/DXS1375E deletion syndrome.
Alias Symbols: 6C6-AG, BAP31, CDM, DXS1357E
Protein Interaction Partner: PTPLB,ACTG1,APP,BCAP29,BCAP31,BCL2,BCL2L1,CANX,CASP1,CASP3,CASP8,HLA-A,MSN,MYH10,PLP2,PTPLB,VAMP1,VAMP3,ACTG1,BCAP29,BCAP31,BCL2,BCL2L1,CASP1,CASP8,MYH10,VAMP2,VAMP3
Protein Size: 246 -
Molecular Weight
- 28 kDa
-
Gene ID
- 10134
-
NCBI Accession
- NM_005745, NP_005736
-
UniProt
- P51572
Target
-